Home / Inspections / 1240745

FDA Inspection 1240745 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 2618677

The FDA completed an inspection of Baxter Healthcare Corporation on July 19, 2024 in Jayuya, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jayuya, PR (United States)

Facility

Other inspections at this facility

  • 1149615 (NAI Fri Jul 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075479 (VAI Fri Dec 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 985599 (OAI Mon Oct 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925338 (OAI Fri May 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864714 (OAI Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources